Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: Reuters Investment Profile
$20.00
Provider: Wright Reports
$75.00
Provider: Sadif Analytics Prime
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

KOBAYASHI PHARMACEUTICAL CO LTD Lowers Full-year Consolidated Outlook and Raises Year-end Dividend Forecast for FY 2013


Tuesday, 29 Jan 2013 01:00am EST 

KOBAYASHI PHARMACEUTICAL CO LTD announced that it has lowered its full-year consolidated outlook for revenue from JPY 132,000 million to JPY 122,000 million, operating profit from JPY 20,000 million to JPY 16,800 million, ordinary profit from JPY 20,900 million to JPY 18,300 million, net profit from JPY 12,500 million to JPY 12,300 million, and earnings per share from JPY 305.26 to JPY 300.38, for the fiscal year ending March 31, 2013. The Company lowered its full-year consolidated outlook mainly due to the low consumer spending and decrease in sales of cooling products. According to I/B/E/S Estimates, analysts on average are expecting the Company to report its full-year consolidated outlook for revenue of JPY 126,480 million, operating profit of JPY 18,550 million and net profit of JPY 11,970 million, for the same fiscal year. The Company has raised its year-end dividend forecast from JPY 39.00 per share, which was announced on May 1, 2013, to JPY 43.00 per share, for the same fiscal year. 

Company Quote

6480.0
70.0 +1.09%
2:00am EDT